JP2011506417A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011506417A5 JP2011506417A5 JP2010537517A JP2010537517A JP2011506417A5 JP 2011506417 A5 JP2011506417 A5 JP 2011506417A5 JP 2010537517 A JP2010537517 A JP 2010537517A JP 2010537517 A JP2010537517 A JP 2010537517A JP 2011506417 A5 JP2011506417 A5 JP 2011506417A5
- Authority
- JP
- Japan
- Prior art keywords
- thiazol
- ethyl
- benzo
- urea
- methyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 13
- -1 1-ethyl-3- (5- (1- (2-morpholinoethyl) -1H-pyrazol-4-yl) benzo [d] thiazol-2-yl) urea 1- (5- (1H-pyrazol-3-yl) benzo [d] thiazol-2-yl) -3-ethylurea Chemical compound 0.000 claims 10
- 239000004202 carbamide Substances 0.000 claims 7
- 229910052739 hydrogen Inorganic materials 0.000 claims 7
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 239000001257 hydrogen Substances 0.000 claims 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 5
- 125000000623 heterocyclic group Chemical group 0.000 claims 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 5
- 125000006413 ring segment Chemical group 0.000 claims 5
- 125000001424 substituent group Chemical group 0.000 claims 5
- 125000005605 benzo group Chemical group 0.000 claims 4
- 150000001204 N-oxides Chemical class 0.000 claims 3
- 150000002431 hydrogen Chemical class 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 125000003386 piperidinyl group Chemical group 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- DNCYBUMDUBHIJZ-UHFFFAOYSA-N 1h-pyrimidin-6-one Chemical class O=C1C=CN=CN1 DNCYBUMDUBHIJZ-UHFFFAOYSA-N 0.000 claims 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical class C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 2
- UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical class OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 claims 2
- 125000004076 pyridyl group Chemical group 0.000 claims 2
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 2
- 125000000437 thiazol-2-yl group Chemical group [H]C1=C([H])N=C(*)S1 0.000 claims 2
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 claims 1
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims 1
- OJEJUFGAKHQYSC-UHFFFAOYSA-N 1-[5-(3,4-dihydro-2h-pyrido[3,2-b][1,4]oxazin-7-yl)-1,3-benzothiazol-2-yl]-3-ethylurea Chemical compound N1CCOC2=CC(C=3C=C4N=C(SC4=CC=3)NC(=O)NCC)=CN=C21 OJEJUFGAKHQYSC-UHFFFAOYSA-N 0.000 claims 1
- FQDMAJAJQGUZKU-UHFFFAOYSA-N 1-[5-[1-(2-ethoxyethyl)-6-oxopyridin-3-yl]-1,3-benzothiazol-2-yl]-3-ethylurea Chemical compound C=1C=C2SC(NC(=O)NCC)=NC2=CC=1C=1C=CC(=O)N(CCOCC)C=1 FQDMAJAJQGUZKU-UHFFFAOYSA-N 0.000 claims 1
- AJEYDFVTRGYAPW-UHFFFAOYSA-N 1-[5-[1-[2-(dimethylamino)ethyl]-2-oxopyridin-4-yl]-6-fluoro-1,3-benzothiazol-2-yl]-3-ethylurea Chemical compound FC=1C=C2SC(NC(=O)NCC)=NC2=CC=1C=1C=CN(CCN(C)C)C(=O)C=1 AJEYDFVTRGYAPW-UHFFFAOYSA-N 0.000 claims 1
- FEZCMLSGFJEISW-UHFFFAOYSA-N 1-[5-[1-[3-(dimethylamino)propyl]-2-methyl-6-oxopyridin-4-yl]-6-fluoro-1,3-benzothiazol-2-yl]-3-ethylurea Chemical compound FC=1C=C2SC(NC(=O)NCC)=NC2=CC=1C=1C=C(C)N(CCCN(C)C)C(=O)C=1 FEZCMLSGFJEISW-UHFFFAOYSA-N 0.000 claims 1
- KDXZKBAHQKXWHE-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-6-fluoro-1,3-benzothiazol-5-yl]pyrimidin-2-yl]piperidine-3-carboxylic acid Chemical compound FC=1C=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCCC(C(O)=O)C1 KDXZKBAHQKXWHE-UHFFFAOYSA-N 0.000 claims 1
- LCOMOVQMUQSDLR-UHFFFAOYSA-N 1-[5-[2-(ethylcarbamoylamino)-6-fluoro-1,3-benzothiazol-5-yl]pyrimidin-2-yl]piperidine-4-carboxylic acid Chemical compound FC=1C=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCC(C(O)=O)CC1 LCOMOVQMUQSDLR-UHFFFAOYSA-N 0.000 claims 1
- SFMXVVTWITVKDF-UHFFFAOYSA-N 1-ethyl-3-(5-imidazo[1,2-a]pyridin-3-yl-1,3-benzothiazol-2-yl)urea Chemical compound C1=CC=CN2C(C=3C=C4N=C(SC4=CC=3)NC(=O)NCC)=CN=C21 SFMXVVTWITVKDF-UHFFFAOYSA-N 0.000 claims 1
- UVJOZSJQTBNSBC-UHFFFAOYSA-N 1-ethyl-3-(5-imidazo[1,2-a]pyridin-6-yl-1,3-benzothiazol-2-yl)urea Chemical compound C1=CC2=NC=CN2C=C1C1=CC=C(SC(NC(=O)NCC)=N2)C2=C1 UVJOZSJQTBNSBC-UHFFFAOYSA-N 0.000 claims 1
- BMIPFLDVVQUCKM-UHFFFAOYSA-N 1-ethyl-3-(5-isoquinolin-4-yl-1,3-benzothiazol-2-yl)urea Chemical compound C1=CC=C2C(C=3C=C4N=C(SC4=CC=3)NC(=O)NCC)=CN=CC2=C1 BMIPFLDVVQUCKM-UHFFFAOYSA-N 0.000 claims 1
- JUZOPGNAEFIKMI-UHFFFAOYSA-N 1-ethyl-3-(5-pyridin-3-yl-1,3-benzothiazol-2-yl)urea Chemical compound C=1C=C2SC(NC(=O)NCC)=NC2=CC=1C1=CC=CN=C1 JUZOPGNAEFIKMI-UHFFFAOYSA-N 0.000 claims 1
- SESBOEYJZCQDBQ-UHFFFAOYSA-N 1-ethyl-3-(6-fluoro-5-pyridin-3-yl-1,3-benzothiazol-2-yl)urea Chemical compound FC=1C=C2SC(NC(=O)NCC)=NC2=CC=1C1=CC=CN=C1 SESBOEYJZCQDBQ-UHFFFAOYSA-N 0.000 claims 1
- PDKCJJJNEIYSTR-UHFFFAOYSA-N 1-ethyl-3-(6-methoxy-5-pyridin-3-yl-1,3-benzothiazol-2-yl)urea Chemical compound COC=1C=C2SC(NC(=O)NCC)=NC2=CC=1C1=CC=CN=C1 PDKCJJJNEIYSTR-UHFFFAOYSA-N 0.000 claims 1
- LCRAXLYNKHWKRF-UHFFFAOYSA-N 1-ethyl-3-(6-methyl-5-pyridin-3-yl-1,3-benzothiazol-2-yl)urea Chemical compound CC=1C=C2SC(NC(=O)NCC)=NC2=CC=1C1=CC=CN=C1 LCRAXLYNKHWKRF-UHFFFAOYSA-N 0.000 claims 1
- OJIRJPXQGLKPLX-UHFFFAOYSA-N 1-ethyl-3-(6-pyridin-3-yl-[1,3]thiazolo[5,4-b]pyridin-2-yl)urea Chemical compound C=1N=C2SC(NC(=O)NCC)=NC2=CC=1C1=CC=CN=C1 OJIRJPXQGLKPLX-UHFFFAOYSA-N 0.000 claims 1
- ICIZQHAUBHCDNR-UHFFFAOYSA-N 1-ethyl-3-[5-(1-methyl-2-oxopyridin-4-yl)-1,3-benzothiazol-2-yl]urea Chemical compound C=1C=C2SC(NC(=O)NCC)=NC2=CC=1C=1C=CN(C)C(=O)C=1 ICIZQHAUBHCDNR-UHFFFAOYSA-N 0.000 claims 1
- KBYWLNLMISYCJJ-UHFFFAOYSA-N 1-ethyl-3-[5-(1-methylpyrazol-4-yl)-1,3-benzothiazol-2-yl]urea Chemical compound C=1C=C2SC(NC(=O)NCC)=NC2=CC=1C=1C=NN(C)C=1 KBYWLNLMISYCJJ-UHFFFAOYSA-N 0.000 claims 1
- DOZXCIUTWZEEFA-UHFFFAOYSA-N 1-ethyl-3-[5-(1h-pyrazol-4-yl)-1,3-benzothiazol-2-yl]urea Chemical compound C=1C=C2SC(NC(=O)NCC)=NC2=CC=1C=1C=NNC=1 DOZXCIUTWZEEFA-UHFFFAOYSA-N 0.000 claims 1
- IERZWUZDMPGDGZ-UHFFFAOYSA-N 1-ethyl-3-[5-(2-imidazol-1-ylpyrimidin-5-yl)-1,3-benzothiazol-2-yl]urea Chemical compound C=1C=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1C=CN=C1 IERZWUZDMPGDGZ-UHFFFAOYSA-N 0.000 claims 1
- WDNOXIWYTZTYIJ-UHFFFAOYSA-N 1-ethyl-3-[5-(2-methoxy-1,3-thiazol-5-yl)-1,3-benzothiazol-2-yl]urea Chemical compound C=1C=C2SC(NC(=O)NCC)=NC2=CC=1C1=CN=C(OC)S1 WDNOXIWYTZTYIJ-UHFFFAOYSA-N 0.000 claims 1
- PJIDOBXNQXKBPI-UHFFFAOYSA-N 1-ethyl-3-[5-(2-methyl-6-oxopyran-4-yl)-1,3-benzothiazol-2-yl]urea Chemical compound C=1C=C2SC(NC(=O)NCC)=NC2=CC=1C=1C=C(C)OC(=O)C=1 PJIDOBXNQXKBPI-UHFFFAOYSA-N 0.000 claims 1
- KUAXFNLPHDBQLR-UHFFFAOYSA-N 1-ethyl-3-[5-(2-oxo-1h-pyridin-4-yl)-1,3-benzothiazol-2-yl]urea Chemical compound C=1C=C2SC(NC(=O)NCC)=NC2=CC=1C=1C=CNC(=O)C=1 KUAXFNLPHDBQLR-UHFFFAOYSA-N 0.000 claims 1
- DXWPTVSFXJWYGK-UHFFFAOYSA-N 1-ethyl-3-[5-(2-oxo-3h-1,3-thiazol-5-yl)-1,3-benzothiazol-2-yl]urea Chemical compound C=1C=C2SC(NC(=O)NCC)=NC2=CC=1C1=CN=C(O)S1 DXWPTVSFXJWYGK-UHFFFAOYSA-N 0.000 claims 1
- DVLHFOLCJLLICM-UHFFFAOYSA-N 1-ethyl-3-[5-(6-morpholin-4-ylpyridin-3-yl)-1,3-benzothiazol-2-yl]urea Chemical compound C=1C=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CC=C1N1CCOCC1 DVLHFOLCJLLICM-UHFFFAOYSA-N 0.000 claims 1
- NPGBSWIIMNZWLH-UHFFFAOYSA-N 1-ethyl-3-[5-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1,3-benzothiazol-2-yl]urea Chemical compound C1=CC2=NC=NN2C=C1C1=CC=C(SC(NC(=O)NCC)=N2)C2=C1 NPGBSWIIMNZWLH-UHFFFAOYSA-N 0.000 claims 1
- PJYWQWOTVHBJOX-UHFFFAOYSA-N 1-ethyl-3-[5-([1,2,4]triazolo[4,3-a]pyridin-6-yl)-1,3-benzothiazol-2-yl]urea Chemical compound C1=CC2=NN=CN2C=C1C1=CC=C(SC(NC(=O)NCC)=N2)C2=C1 PJYWQWOTVHBJOX-UHFFFAOYSA-N 0.000 claims 1
- ZCVPLGHYRBGXJA-UHFFFAOYSA-N 1-ethyl-3-[5-(tetrazolo[1,5-a]pyridin-6-yl)-1,3-benzothiazol-2-yl]urea Chemical compound C1=CC2=NN=NN2C=C1C1=CC=C(SC(NC(=O)NCC)=N2)C2=C1 ZCVPLGHYRBGXJA-UHFFFAOYSA-N 0.000 claims 1
- RTGPBFZARVRBQG-UHFFFAOYSA-N 1-ethyl-3-[5-[1-(2-hydroxyethyl)-2-methyl-6-oxopyridin-4-yl]-1,3-benzothiazol-2-yl]urea Chemical compound C=1C=C2SC(NC(=O)NCC)=NC2=CC=1C=1C=C(C)N(CCO)C(=O)C=1 RTGPBFZARVRBQG-UHFFFAOYSA-N 0.000 claims 1
- GTWCSQSSJHDDRA-UHFFFAOYSA-N 1-ethyl-3-[5-[1-(2-methoxyethyl)-2-methyl-6-oxopyridin-4-yl]-1,3-benzothiazol-2-yl]urea Chemical compound C=1C=C2SC(NC(=O)NCC)=NC2=CC=1C=1C=C(C)N(CCOC)C(=O)C=1 GTWCSQSSJHDDRA-UHFFFAOYSA-N 0.000 claims 1
- XOCHVIVRFUZYLK-UHFFFAOYSA-N 1-ethyl-3-[5-[2-(hydroxymethyl)-3-methylimidazol-4-yl]-1,3-benzothiazol-2-yl]urea Chemical compound C=1C=C2SC(NC(=O)NCC)=NC2=CC=1C1=CN=C(CO)N1C XOCHVIVRFUZYLK-UHFFFAOYSA-N 0.000 claims 1
- YQEOHQLMFVMQRC-UHFFFAOYSA-N 1-ethyl-3-[5-[2-methyl-1-[(6-methylpyridin-2-yl)methyl]-6-oxopyridin-4-yl]-1,3-benzothiazol-2-yl]urea Chemical compound C=1C=C2SC(NC(=O)NCC)=NC2=CC=1C(=CC1=O)C=C(C)N1CC1=CC=CC(C)=N1 YQEOHQLMFVMQRC-UHFFFAOYSA-N 0.000 claims 1
- VRJPCTKUYUJVMD-UHFFFAOYSA-N 1-ethyl-3-[5-[2-methyl-6-oxo-1-(pyridin-2-ylmethyl)pyridin-4-yl]-1,3-benzothiazol-2-yl]urea Chemical compound C=1C=C2SC(NC(=O)NCC)=NC2=CC=1C(=CC1=O)C=C(C)N1CC1=CC=CC=N1 VRJPCTKUYUJVMD-UHFFFAOYSA-N 0.000 claims 1
- YTOMRFZBGJFQDF-UHFFFAOYSA-N 1-ethyl-3-[5-[2-methyl-6-oxo-1-(pyridin-3-ylmethyl)pyridin-4-yl]-1,3-benzothiazol-2-yl]urea Chemical compound C=1C=C2SC(NC(=O)NCC)=NC2=CC=1C(=CC1=O)C=C(C)N1CC1=CC=CN=C1 YTOMRFZBGJFQDF-UHFFFAOYSA-N 0.000 claims 1
- AUMSVPWMSORTBR-UHFFFAOYSA-N 1-ethyl-3-[5-[5-(2-oxopyridin-1-yl)pyrazin-2-yl]-1,3-benzothiazol-2-yl]urea Chemical compound C=1C=C2SC(NC(=O)NCC)=NC2=CC=1C(N=C1)=CN=C1N1C=CC=CC1=O AUMSVPWMSORTBR-UHFFFAOYSA-N 0.000 claims 1
- ICTNNBOJDBSQTE-UHFFFAOYSA-N 1-ethyl-3-[5-[6-(2-methyltetrazol-5-yl)pyridin-3-yl]-1,3-benzothiazol-2-yl]urea Chemical compound C=1C=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CC=C1C=1N=NN(C)N=1 ICTNNBOJDBSQTE-UHFFFAOYSA-N 0.000 claims 1
- CPPMKAZKQCKFRT-UHFFFAOYSA-N 1-ethyl-3-[5-[6-(hydroxymethyl)pyridin-3-yl]-1,3-benzothiazol-2-yl]urea Chemical compound C=1C=C2SC(NC(=O)NCC)=NC2=CC=1C1=CC=C(CO)N=C1 CPPMKAZKQCKFRT-UHFFFAOYSA-N 0.000 claims 1
- XRRFWZVFIZUJQM-UHFFFAOYSA-N 1-ethyl-3-[6-(2-methyl-6-oxopyran-4-yl)-[1,3]thiazolo[5,4-b]pyridin-2-yl]urea Chemical compound C=1N=C2SC(NC(=O)NCC)=NC2=CC=1C=1C=C(C)OC(=O)C=1 XRRFWZVFIZUJQM-UHFFFAOYSA-N 0.000 claims 1
- VIIUMBFCEKKFAH-UHFFFAOYSA-N 1-ethyl-3-[6-fluoro-5-(1,3-thiazol-5-yl)-1,3-benzothiazol-2-yl]urea Chemical compound FC=1C=C2SC(NC(=O)NCC)=NC2=CC=1C1=CN=CS1 VIIUMBFCEKKFAH-UHFFFAOYSA-N 0.000 claims 1
- SFAIZLCVDNVGGJ-UHFFFAOYSA-N 1-ethyl-3-[6-fluoro-5-(1-methyl-2-oxopyridin-4-yl)-1,3-benzothiazol-2-yl]urea Chemical compound FC=1C=C2SC(NC(=O)NCC)=NC2=CC=1C=1C=CN(C)C(=O)C=1 SFAIZLCVDNVGGJ-UHFFFAOYSA-N 0.000 claims 1
- LSZDLXKNEREMBW-UHFFFAOYSA-N 1-ethyl-3-[6-fluoro-5-(1h-pyrrolo[2,3-b]pyridin-3-yl)-1,3-benzothiazol-2-yl]urea Chemical compound C1=CC=C2C(C=3C=C4N=C(SC4=CC=3F)NC(=O)NCC)=CNC2=N1 LSZDLXKNEREMBW-UHFFFAOYSA-N 0.000 claims 1
- WQCUFLPVZRAJKU-UHFFFAOYSA-N 1-ethyl-3-[6-fluoro-5-(2-methylsulfonylpyrimidin-5-yl)-1,3-benzothiazol-2-yl]urea Chemical compound FC=1C=C2SC(NC(=O)NCC)=NC2=CC=1C1=CN=C(S(C)(=O)=O)N=C1 WQCUFLPVZRAJKU-UHFFFAOYSA-N 0.000 claims 1
- SZTVSKREVPNNNI-UHFFFAOYSA-N 1-ethyl-3-[6-fluoro-5-(2-oxo-1-pyrrolidin-3-ylpyridin-4-yl)-1,3-benzothiazol-2-yl]urea Chemical compound FC=1C=C2SC(NC(=O)NCC)=NC2=CC=1C(=CC1=O)C=CN1C1CCNC1 SZTVSKREVPNNNI-UHFFFAOYSA-N 0.000 claims 1
- HYXWDZXHFJPHJW-UHFFFAOYSA-N 1-ethyl-3-[6-fluoro-5-(2-piperazin-1-ylpyrimidin-5-yl)-1,3-benzothiazol-2-yl]urea;hydrochloride Chemical compound Cl.FC=1C=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCNCC1 HYXWDZXHFJPHJW-UHFFFAOYSA-N 0.000 claims 1
- CDRBZIWHZFQOGA-UHFFFAOYSA-N 1-ethyl-3-[6-fluoro-5-(4-methoxypyridin-2-yl)-1,3-benzothiazol-2-yl]urea Chemical compound FC=1C=C2SC(NC(=O)NCC)=NC2=CC=1C1=CC(OC)=CC=N1 CDRBZIWHZFQOGA-UHFFFAOYSA-N 0.000 claims 1
- RWBYPNPZWLOZBK-UHFFFAOYSA-N 1-ethyl-3-[6-fluoro-5-(5-hydroxypyridin-3-yl)-1,3-benzothiazol-2-yl]urea Chemical compound FC=1C=C2SC(NC(=O)NCC)=NC2=CC=1C1=CN=CC(O)=C1 RWBYPNPZWLOZBK-UHFFFAOYSA-N 0.000 claims 1
- YXDKIVLKMWAVNA-UHFFFAOYSA-N 1-ethyl-3-[6-fluoro-5-(5-methoxypyridin-3-yl)-1,3-benzothiazol-2-yl]urea Chemical compound FC=1C=C2SC(NC(=O)NCC)=NC2=CC=1C1=CN=CC(OC)=C1 YXDKIVLKMWAVNA-UHFFFAOYSA-N 0.000 claims 1
- WBXQNQAKOAPQIS-UHFFFAOYSA-N 1-ethyl-3-[6-fluoro-5-[1-(2-morpholin-4-ylethyl)-2-oxopyridin-4-yl]-1,3-benzothiazol-2-yl]urea Chemical compound FC=1C=C2SC(NC(=O)NCC)=NC2=CC=1C(=CC1=O)C=CN1CCN1CCOCC1 WBXQNQAKOAPQIS-UHFFFAOYSA-N 0.000 claims 1
- CJEOICZZUAJJTM-UHFFFAOYSA-N 1-ethyl-3-[6-fluoro-5-[2-(4-methylpiperazin-1-yl)pyrimidin-5-yl]-1,3-benzothiazol-2-yl]urea Chemical compound FC=1C=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCN(C)CC1 CJEOICZZUAJJTM-UHFFFAOYSA-N 0.000 claims 1
- GKZOCNOYDIKRMN-UHFFFAOYSA-N 1-ethyl-3-[6-fluoro-5-[2-[4-(2-hydroxyethyl)piperazin-1-yl]pyrimidin-5-yl]-1,3-benzothiazol-2-yl]urea Chemical compound FC=1C=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CN=C1N1CCN(CCO)CC1 GKZOCNOYDIKRMN-UHFFFAOYSA-N 0.000 claims 1
- IGPLFESYPJKUIT-UHFFFAOYSA-N 1-ethyl-3-[6-fluoro-5-[2-methyl-1-[(1-methylimidazol-4-yl)methyl]-6-oxopyridin-4-yl]-1,3-benzothiazol-2-yl]urea Chemical compound FC=1C=C2SC(NC(=O)NCC)=NC2=CC=1C(=CC1=O)C=C(C)N1CC1=CN(C)C=N1 IGPLFESYPJKUIT-UHFFFAOYSA-N 0.000 claims 1
- ZWMXKXNCZAXWND-UHFFFAOYSA-N 1-ethyl-3-[6-fluoro-5-[2-methyl-1-[1-(6-methylpyridin-3-yl)ethyl]-6-oxopyridin-4-yl]-1,3-benzothiazol-2-yl]urea Chemical compound FC=1C=C2SC(NC(=O)NCC)=NC2=CC=1C(=CC1=O)C=C(C)N1C(C)C1=CC=C(C)N=C1 ZWMXKXNCZAXWND-UHFFFAOYSA-N 0.000 claims 1
- COWUIVSDMZNIOO-UHFFFAOYSA-N 1-ethyl-3-[6-fluoro-5-[6-(hydroxymethyl)pyridin-3-yl]-1,3-benzothiazol-2-yl]urea Chemical compound FC=1C=C2SC(NC(=O)NCC)=NC2=CC=1C1=CC=C(CO)N=C1 COWUIVSDMZNIOO-UHFFFAOYSA-N 0.000 claims 1
- RMMFLZYVRZYEJH-UHFFFAOYSA-N 1-ethyl-3-[6-fluoro-5-[6-(morpholin-4-ylmethyl)pyridin-3-yl]-1,3-benzothiazol-2-yl]urea Chemical compound FC=1C=C2SC(NC(=O)NCC)=NC2=CC=1C(C=N1)=CC=C1CN1CCOCC1 RMMFLZYVRZYEJH-UHFFFAOYSA-N 0.000 claims 1
- CCKSWMJYOYEDBJ-UHFFFAOYSA-N 1-ethyl-3-[6-fluoro-5-[6-[(Z)-N'-hydroxycarbamimidoyl]pyridin-3-yl]-1,3-benzothiazol-2-yl]urea Chemical compound FC=1C=C2SC(NC(=O)NCC)=NC2=CC=1C1=CC=C(C(N)=NO)N=C1 CCKSWMJYOYEDBJ-UHFFFAOYSA-N 0.000 claims 1
- CBQNUCICVBMAEN-UHFFFAOYSA-N 1-ethyl-3-[6-methoxy-5-(1-methyl-2-oxopyridin-4-yl)-1,3-benzothiazol-2-yl]urea Chemical compound COC=1C=C2SC(NC(=O)NCC)=NC2=CC=1C=1C=CN(C)C(=O)C=1 CBQNUCICVBMAEN-UHFFFAOYSA-N 0.000 claims 1
- JWQRMITVLGIGCV-UHFFFAOYSA-N 2-[5-[2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyridin-2-yl]-n-methylacetamide Chemical compound C=1C=C2SC(NC(=O)NCC)=NC2=CC=1C1=CC=C(CC(=O)NC)N=C1 JWQRMITVLGIGCV-UHFFFAOYSA-N 0.000 claims 1
- JFYRHAFXWNLJHD-UHFFFAOYSA-N 2-[5-[2-(ethylcarbamoylamino)-6-fluoro-1,3-benzothiazol-5-yl]pyridin-2-yl]-n-methylacetamide Chemical compound FC=1C=C2SC(NC(=O)NCC)=NC2=CC=1C1=CC=C(CC(=O)NC)N=C1 JFYRHAFXWNLJHD-UHFFFAOYSA-N 0.000 claims 1
- ZPSJGADGUYYRKE-UHFFFAOYSA-N 2H-pyran-2-one Chemical class O=C1C=CC=CO1 ZPSJGADGUYYRKE-UHFFFAOYSA-N 0.000 claims 1
- 208000035143 Bacterial infection Diseases 0.000 claims 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Chemical class C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 claims 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical class C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims 1
- 125000004450 alkenylene group Chemical group 0.000 claims 1
- 125000004419 alkynylene group Chemical group 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 208000022362 bacterial infectious disease Diseases 0.000 claims 1
- 125000002527 bicyclic carbocyclic group Chemical group 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- LEMCBKVVDHBCFN-UHFFFAOYSA-N ethyl 7-[2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]-1-methyl-4-oxoquinoline-3-carboxylate Chemical compound CN1C=C(C(=O)OCC)C(=O)C=2C1=CC(C=1C=C3N=C(SC3=CC=1)NC(=O)NCC)=CC=2 LEMCBKVVDHBCFN-UHFFFAOYSA-N 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 125000001475 halogen functional group Chemical group 0.000 claims 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 1
- 125000001620 monocyclic carbocycle group Chemical group 0.000 claims 1
- 125000002757 morpholinyl group Chemical group 0.000 claims 1
- RCWOKJMBZJIAFP-UHFFFAOYSA-N n-[5-[2-(ethylcarbamoylamino)-1,3-benzothiazol-5-yl]pyridin-2-yl]acetamide Chemical compound C=1C=C2SC(NC(=O)NCC)=NC2=CC=1C1=CC=C(NC(C)=O)N=C1 RCWOKJMBZJIAFP-UHFFFAOYSA-N 0.000 claims 1
- NEDNPDQFFWXYMP-UHFFFAOYSA-N n-[5-[2-(ethylcarbamoylamino)-6-fluoro-1,3-benzothiazol-5-yl]pyridin-2-yl]acetamide Chemical compound FC=1C=C2SC(NC(=O)NCC)=NC2=CC=1C1=CC=C(NC(C)=O)N=C1 NEDNPDQFFWXYMP-UHFFFAOYSA-N 0.000 claims 1
- FUBZAHXLDYKNDC-UHFFFAOYSA-N n-[5-[2-(ethylcarbamoylamino)-[1,3]thiazolo[5,4-b]pyridin-6-yl]pyridin-2-yl]acetamide Chemical compound C=1N=C2SC(NC(=O)NCC)=NC2=CC=1C1=CC=C(NC(C)=O)N=C1 FUBZAHXLDYKNDC-UHFFFAOYSA-N 0.000 claims 1
- 125000001715 oxadiazolyl group Chemical group 0.000 claims 1
- 125000004043 oxo group Chemical group O=* 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 125000004193 piperazinyl group Chemical group 0.000 claims 1
- DNUTZBZXLPWRJG-UHFFFAOYSA-M piperidine-1-carboxylate Chemical compound [O-]C(=O)N1CCCCC1 DNUTZBZXLPWRJG-UHFFFAOYSA-M 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 230000000069 prophylactic effect Effects 0.000 claims 1
- 125000003373 pyrazinyl group Chemical group 0.000 claims 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 1
- 150000003222 pyridines Chemical class 0.000 claims 1
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 1
- NYCVCXMSZNOGDH-UHFFFAOYSA-N pyrrolidine-1-carboxylic acid Chemical compound OC(=O)N1CCCC1 NYCVCXMSZNOGDH-UHFFFAOYSA-N 0.000 claims 1
- 125000003831 tetrazolyl group Chemical group 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 150000003568 thioethers Chemical class 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0724342.1 | 2007-12-13 | ||
| GBGB0724342.1A GB0724342D0 (en) | 2007-12-13 | 2007-12-13 | Anitbacterial compositions |
| PCT/GB2008/004114 WO2009074812A1 (en) | 2007-12-13 | 2008-12-12 | Antibacterial condensed thiazoles |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011506417A JP2011506417A (ja) | 2011-03-03 |
| JP2011506417A5 true JP2011506417A5 (https=) | 2012-02-16 |
| JP5539898B2 JP5539898B2 (ja) | 2014-07-02 |
Family
ID=39048076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010537517A Expired - Fee Related JP5539898B2 (ja) | 2007-12-13 | 2008-12-12 | 抗菌活性縮合チアゾール |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8299065B2 (https=) |
| EP (1) | EP2231653B1 (https=) |
| JP (1) | JP5539898B2 (https=) |
| KR (1) | KR20100105847A (https=) |
| CN (1) | CN102015700B (https=) |
| AU (1) | AU2008334427B2 (https=) |
| BR (1) | BRPI0820656A2 (https=) |
| CA (1) | CA2709021A1 (https=) |
| EA (1) | EA018104B1 (https=) |
| ES (1) | ES2416059T3 (https=) |
| GB (1) | GB0724342D0 (https=) |
| MX (1) | MX2010006428A (https=) |
| NZ (1) | NZ586508A (https=) |
| WO (1) | WO2009074812A1 (https=) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2725689A1 (en) * | 2008-06-04 | 2009-12-10 | Astrazeneca Ab | Thiazolo [5,4-b] pyridine and oxazolo [5,4-b] pyridine derivatives as antibacterial agents |
| EP2321309A1 (en) * | 2008-06-25 | 2011-05-18 | Ranbaxy Laboratories Limited | Benzothiazoles and aza-analogues thereof use as antibacterial agents |
| MX2012004341A (es) | 2009-10-16 | 2012-10-05 | Rib X Pharmaceuticals Inc | Compuestos antimicrobianos y metodos para fabricar y utilizar los mismos. |
| EA201270566A1 (ru) * | 2009-10-16 | 2012-11-30 | Риб-Экс Фармасьютикалз, Инк. | Противомикробные соединения и способы их получения и применения |
| NZ599290A (en) | 2009-10-16 | 2014-10-31 | Melinta Therapeutics Inc | Antimicrobial compounds and methods of making and using the same |
| BR112012024705A2 (pt) * | 2010-03-31 | 2016-06-07 | Actelion Pharmaceuticals Ltd | derivados antibacterianos de isoquinolin-3-ilureia |
| US8648192B2 (en) | 2010-05-26 | 2014-02-11 | Boehringer Ingelheim International Gmbh | 2-oxo-1,2-dihydropyridin-4-ylboronic acid derivatives |
| WO2012045124A1 (en) * | 2010-10-08 | 2012-04-12 | Biota Europe Ltd | Bacteria topoisomerase ii inhibiting 2-ethylcarbamoylamino-1, 3-benzothiazol-5-yls |
| US8476281B2 (en) | 2011-01-14 | 2013-07-02 | Vertex Pharmaceuticals Incorporated | Solid forms of gyrase inhibitor (R)-1-ethyl-3-[6-fluoro-5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl)-1H-benzimidazol-2-yl]urea |
| CN103384665B (zh) | 2011-01-14 | 2018-01-09 | 斯派罗吹耐姆公司 | 制备促旋酶和拓扑异构酶抑制剂的方法 |
| AU2012205415B2 (en) | 2011-01-14 | 2017-02-02 | Spero Therapeutics, Inc. | Pyrimidine gyrase and topoisomerase IV inhibitors |
| WO2012097270A1 (en) | 2011-01-14 | 2012-07-19 | Vertex Pharmaceuticals Incorporated | Solid forms of gyrase inhibitor (r)-1-ethyl-3-[5-[2-{1-hydroxy-1-methyl-ethyl}pyrimidin-5-yl]-7-(tetrahydrofuran-2-yl}-1h-benzimidazol-2-yl]urea |
| EP2691399B1 (en) * | 2011-03-28 | 2016-07-13 | F.Hoffmann-La Roche Ag | Thiazolopyrimidine compounds |
| AR088729A1 (es) | 2011-03-29 | 2014-07-02 | Actelion Pharmaceuticals Ltd | Derivados de 3-ureidoisoquinolin-8-ilo y una composicion farmaceutica |
| MY173518A (en) | 2011-04-15 | 2020-01-30 | Melinta Therapeutics Inc | Antimicrobial compounds and methods of making and using the same |
| CN103702994B (zh) | 2011-06-20 | 2016-03-23 | 沃泰克斯药物股份有限公司 | 旋转酶和拓扑异构酶抑制剂的磷酸酯 |
| WO2013106756A2 (en) | 2012-01-13 | 2013-07-18 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
| EP2828245A1 (en) | 2012-03-21 | 2015-01-28 | Rutgers, The State University of New Jersey | Antimicrobial agents |
| WO2013138860A1 (en) | 2012-03-22 | 2013-09-26 | Biota Europe Limited | Antibacterial compounds |
| CA2878481A1 (en) * | 2012-07-10 | 2014-01-16 | Bayer Pharma Aktiengesellschaft | Method for preparing substituted triazolopyridines |
| US9572809B2 (en) | 2012-07-18 | 2017-02-21 | Spero Trinem, Inc. | Combination therapy to treat Mycobacterium diseases |
| WO2014015105A1 (en) | 2012-07-18 | 2014-01-23 | Vertex Pharmaceuticals Incorporated | Solid forms of (r)-2-(5-(2-(3-ethylureido)-6-fluoro-7-(tetrahydrofuran-2-yl)-1h-benzo[d]imidazol-5-yl)pyrimidin-2-yl)propan-2-yl dihydrogen phosphate and salts thereof |
| US9434695B2 (en) | 2012-07-18 | 2016-09-06 | Sunshine Lake Pharma Co., Ltd | Nitrogenous heterocyclic derivatives and their application in drugs |
| SG11201504873RA (en) | 2012-12-21 | 2015-07-30 | Janssen Sciences Ireland Uc | Antibacterial compounds |
| EP3038623A4 (en) | 2013-09-09 | 2017-04-19 | Melinta Therapeutics, Inc. | Antimicrobial compounds and methods of making and using the same |
| CA2923214A1 (en) | 2013-09-09 | 2015-03-12 | Melinta Therapeutics, Inc. | Antimicrobial compounds and methods of making and using the same |
| US9458150B2 (en) | 2013-11-08 | 2016-10-04 | Rutgers, The State University Of New Jersey | Antimicrobial agents |
| MX2016010057A (es) | 2014-02-03 | 2017-04-27 | Spero Gyrase Inc | Compuestos antibacterianos. |
| CN105367547B (zh) * | 2014-08-19 | 2019-04-23 | 北京桦冠生物技术有限公司 | 一种噁唑啉酮抗生素的新合成工艺 |
| AR102215A1 (es) * | 2014-10-10 | 2017-02-15 | Glaxosmithkline Ip Dev Ltd | Compuesto de pirazol-4-carboxamida, composición farmacéutica que lo comprende y su uso para la fabricación de un medicamento |
| HK1249758A1 (zh) | 2015-03-11 | 2018-11-09 | Melinta Therapeutics, Inc. | 抗微生物化合物及其制备和使用方法 |
| US10513528B2 (en) | 2016-02-25 | 2019-12-24 | Taxis Pharmaceuticals, Inc. | Synthetic processes and intermediates |
| EP3439655B1 (en) | 2016-04-08 | 2021-03-03 | Quretech Bio AB | Ring-fused thiazolino 2-pyridones, methods for preparation thereof and their use in the treatment and/or prevention of tuberculosis |
| US11098047B2 (en) | 2016-05-06 | 2021-08-24 | BioVersys AG | Antimicrobials and methods of making and using same |
| CA3057431A1 (en) | 2017-03-24 | 2018-09-27 | Taisho Pharmaceutical Co., Ltd. | 2(1h)-quinolinone derivative |
| WO2018183917A1 (en) | 2017-03-30 | 2018-10-04 | Taxis Pharmaceuticals, Inc. | Synthetic processes and synthetic intermediates |
| CN107325093B (zh) * | 2017-07-09 | 2020-06-05 | 西南科技大学 | 具抗菌活性的硫脲类化合物合成及应用 |
| WO2019162458A1 (en) | 2018-02-23 | 2019-08-29 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Novel inhibitors of bacterial glutaminyl cyclases for use in the treatment of periodontal and related diseases |
| CN114945366B (zh) | 2019-09-13 | 2025-01-07 | 林伯士萨顿公司 | Hpk1拮抗剂和其用途 |
| CN117120090A (zh) | 2021-02-12 | 2023-11-24 | 林伯士萨顿公司 | Hpk1拮抗剂和其用途 |
| EP4301756A4 (en) | 2021-03-05 | 2025-02-26 | Nimbus Saturn, Inc. | Hpk1 antagonists and uses thereof |
| WO2022213062A1 (en) | 2021-03-29 | 2022-10-06 | Nimbus Saturn, Inc. | Hpk1 antagonists and uses thereof |
| WO2025202955A1 (en) | 2024-03-28 | 2025-10-02 | Pi Industries Ltd. | Fused bicyclic compounds and their use as pest control agents |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH505543A (de) * | 1968-11-01 | 1971-04-15 | Ciba Geigy Ag | Schädlingsbekämpfungsmittel |
| US4028374A (en) * | 1975-11-03 | 1977-06-07 | Morton-Norwich Products, Inc. | Antibacterial thiocyanatobenzothiazoles |
| JPS57149280A (en) * | 1981-03-10 | 1982-09-14 | Kyowa Hakko Kogyo Co Ltd | Amino acid derivative and its preparation |
| JP2003521543A (ja) * | 2000-02-07 | 2003-07-15 | アボット ゲーエムベーハー ウント カンパニー カーゲー | ２−ベンゾチアゾリル尿素誘導体およびそのプロテインキナーゼ阻害剤としての使用 |
| AU8181701A (en) | 2000-06-21 | 2002-01-02 | Hoffmann La Roche | Benzothiazole derivatives |
| HUP0303494A3 (en) * | 2000-12-15 | 2009-08-28 | Vertex Pharma | Parmaceutical compositions containing bacterial gyrase inhibitors and uses thereof |
| DE60309701T2 (de) | 2002-06-13 | 2007-09-06 | Vertex Pharmaceuticals Inc., Cambridge | 2-ureido-6-heteroaryl-3h-benzoimidazol-4-carbonsäurederivate und verwandte verbindungen als gyrase und/oder topoisomerase iv inhibitoren zur behandlung von bakteriellen infektionen |
| AR042956A1 (es) | 2003-01-31 | 2005-07-13 | Vertex Pharma | Inhibidores de girasa y usos de los mismos |
| US20050130974A1 (en) | 2003-10-17 | 2005-06-16 | Rigel Pharmaceuticals, Inc. | Benzothiazole compositions and their use as ubiquitin ligase inhibitors |
| TW200621723A (en) * | 2004-09-09 | 2006-07-01 | Chugai Pharmaceutical Co Ltd | Novel imidazolidine derivative and use thereof |
| GB0612428D0 (en) * | 2006-06-22 | 2006-08-02 | Prolysis Ltd | Antibacterial agents |
-
2007
- 2007-12-13 GB GBGB0724342.1A patent/GB0724342D0/en not_active Ceased
-
2008
- 2008-12-12 US US12/747,811 patent/US8299065B2/en not_active Expired - Fee Related
- 2008-12-12 CA CA 2709021 patent/CA2709021A1/en not_active Abandoned
- 2008-12-12 BR BRPI0820656-2A patent/BRPI0820656A2/pt not_active IP Right Cessation
- 2008-12-12 KR KR20107015443A patent/KR20100105847A/ko not_active Ceased
- 2008-12-12 JP JP2010537517A patent/JP5539898B2/ja not_active Expired - Fee Related
- 2008-12-12 EP EP20080859786 patent/EP2231653B1/en not_active Not-in-force
- 2008-12-12 WO PCT/GB2008/004114 patent/WO2009074812A1/en not_active Ceased
- 2008-12-12 MX MX2010006428A patent/MX2010006428A/es active IP Right Grant
- 2008-12-12 NZ NZ586508A patent/NZ586508A/en not_active IP Right Cessation
- 2008-12-12 AU AU2008334427A patent/AU2008334427B2/en not_active Ceased
- 2008-12-12 ES ES08859786T patent/ES2416059T3/es active Active
- 2008-12-12 EA EA201000993A patent/EA018104B1/ru not_active IP Right Cessation
- 2008-12-12 CN CN200880126437.2A patent/CN102015700B/zh not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011506417A5 (https=) | ||
| RU2018138050A (ru) | Производные тиазолопиридина как агонисты gpr119 | |
| US11591336B2 (en) | Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitors | |
| CA2577525A1 (en) | Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same | |
| EP2231653B1 (en) | Antibacterial condensed thiazoles | |
| JP5864589B2 (ja) | 細菌トポイソメラーゼｉｉ阻害性２−エチルカルバモイルアミノ−１，３−ベンゾチアゾール−５−イル類 | |
| CA2845578C (en) | Pyrimidine pde10 inhibitors | |
| JP2013544256A5 (https=) | ||
| HRP20201641T1 (hr) | Novi spojevi i njihove farmaceutske kompozicije za liječenje inflamatornih poremećaja | |
| JP2020514267A5 (https=) | ||
| JP2012525395A5 (https=) | ||
| JP2019536768A5 (https=) | ||
| JP2019514878A5 (https=) | ||
| IL273705B2 (en) | Benzothiazole compounds and methods of using them for the treatment of neurodegenerative diseases | |
| RU2018138047A (ru) | Гетероциклические вещества - агонисты gpr119 | |
| HRP20171998T1 (hr) | Spojevi i sastavi za liječenje parazitnih bolesti | |
| AR119822A1 (es) | Triazolopirimidinas como inhibidores de a2a / a2b | |
| JP2013542204A5 (https=) | ||
| RU2012136643A (ru) | [5,6]- гетероциклическое соединение | |
| RU2015100942A (ru) | Производное пиперидинилпиразолпиридина | |
| JP2017530960A5 (https=) | ||
| JP2013545779A5 (https=) | ||
| RU2012130436A (ru) | Новое антитромботическое средство | |
| HRP20130054T1 (hr) | Spojevi pirazina kao inhibitori fosfodiesteraze 10 | |
| JP2013511486A5 (https=) |